Correlation Between Pfizer and Knorr-Bremse Aktiengesellscha
Can any of the company-specific risk be diversified away by investing in both Pfizer and Knorr-Bremse Aktiengesellscha at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Knorr-Bremse Aktiengesellscha into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Knorr Bremse Aktiengesellschaft, you can compare the effects of market volatilities on Pfizer and Knorr-Bremse Aktiengesellscha and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Knorr-Bremse Aktiengesellscha. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Knorr-Bremse Aktiengesellscha.
Diversification Opportunities for Pfizer and Knorr-Bremse Aktiengesellscha
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pfizer and Knorr-Bremse is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Knorr Bremse Aktiengesellschaf in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Knorr-Bremse Aktiengesellscha and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Knorr-Bremse Aktiengesellscha. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Knorr-Bremse Aktiengesellscha has no effect on the direction of Pfizer i.e., Pfizer and Knorr-Bremse Aktiengesellscha go up and down completely randomly.
Pair Corralation between Pfizer and Knorr-Bremse Aktiengesellscha
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Knorr-Bremse Aktiengesellscha. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 1.08 times less risky than Knorr-Bremse Aktiengesellscha. The stock trades about 0.0 of its potential returns per unit of risk. The Knorr Bremse Aktiengesellschaft is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 1,476 in Knorr Bremse Aktiengesellschaft on September 4, 2024 and sell it today you would earn a total of 410.00 from holding Knorr Bremse Aktiengesellschaft or generate 27.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.6% |
| Values | Daily Returns |
Pfizer Inc vs. Knorr Bremse Aktiengesellschaf
Performance |
| Timeline |
| Pfizer Inc |
| Knorr-Bremse Aktiengesellscha |
Pfizer and Knorr-Bremse Aktiengesellscha Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Knorr-Bremse Aktiengesellscha
The main advantage of trading using opposite Pfizer and Knorr-Bremse Aktiengesellscha positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Knorr-Bremse Aktiengesellscha can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Knorr-Bremse Aktiengesellscha will offset losses from the drop in Knorr-Bremse Aktiengesellscha's long position.| Pfizer vs. Crinetics Pharmaceuticals | Pfizer vs. Enanta Pharmaceuticals | Pfizer vs. Amicus Therapeutics | Pfizer vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |